TIDMAGY

RNS Number : 1587V

Allergy Therapeutics PLC

23 October 2014

23 October 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Annual Report and Accounts

Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company, announces that the Annual Report and Accounts of the Company for the year ended 30 June 2014 and Notice of Annual General Meeting have been posted to shareholders.

The Annual Report and Accounts and Notice of the Annual General Meeting are available on the Company's website in the Investor Relations section. They can be located at http://www.allergytherapeutics.com/Reports%20and%20Presentations%20Sub.aspx for the Annual Report and Accounts and http://www.allergytherapeutics.com/AGM.aspx for the Notice of the Meeting.

For further information

 
 Allergy Therapeutics               +44 (0) 1903 845 820 
 Manuel Llobet, Chief Executive 
  Officer 
  Ian Postlethwaite, Finance 
  Director 
 
 Peel Hunt LLP                      +44 (0) 20 7418 8900 
 James Steel 
  Clare Terlouw 
 
 FTI Consulting                     +44 (0) 20 3727 1000 
 Simon Conway 
  Victoria Foster Mitchell 
 

Notes to editors

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of GBP42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging Markets.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSBSBDGLBDBGSX

Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Allergy Therapeutics Charts.
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Allergy Therapeutics Charts.